September 2026 Quarterly Activities Report & Appendix 4C
Filed with ASX ·
6ix is reading this filing.
Paradigm Biopharmaceuticals Ltd. on 6ix
Earlier from Paradigm Biopharmaceuticals
- Convening Period Extended to 27 January 2027
- Extension of Convening Period
- PPS Shows Significant Pain Benefit in Rest of World Analysis
- Continuation of Suspension from Quotation
- Appointment of Voluntary Administrators
Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.
Follow Paradigm Biopharmaceuticals